Novacyt S.A.: Launch of CE-IVD Marked novel coronavirus test
(WorldNews France)

Novacyt S.A.: Launch of CE-IVD Marked novel coronavirus test 17 Feb 2020 13:30 CET Company Name NOVACYT ISN FR0010397232 Market Euronext Growth Symbol ALNOV Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT) (`Novacyt`, the `Company` or the `Group`), an international specialist in clinical diagnostics, is pleased to announce that its molecular diagnostics division, Primerdesign, has launched its CE-Mark molecular test for the clinical detection of the novel coronavirus (COVID-19). The Directors believe that Primerdesign`s COVID-19 test is the first CE-Mark test for the 2019 strain of novel coronavirus and follows the Company`s rapid launch of its research use only (RUO) coronavirus...